P

Inventor

DUNCTON MATTHEW

US48 patents
⚠️ This page may combine multiple inventors who share the name “DUNCTON MATTHEW”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

RIGEL PHARMACEUTICALS INC

29 patents
US9566278B2Feb 14, 2017

Protein kinase C inhibitors and uses thereof

RIGEL PHARMACEUTICALS INC6 citations84
US9475781B2Oct 25, 2016

Fumarate analogs and uses thereof

RIGEL PHARMACEUTICALS INC11 citations84
US9321763B2Apr 26, 2016

Protein kinase C inhibitors and uses thereof

RIGEL PHARMACEUTICALS INC6 citations84
US8377924B2Feb 19, 2013

Protein kinase C inhibitors and uses thereof

RIGEL PHARMACEUTICALS INC9 citations82
US10941135B2Mar 9, 2021

Nrf2 activating compounds and uses thereof

RIGEL PHARMACEUTICALS INC1 citations73
US9913843B2Mar 13, 2018

Protein kinase C inhibitors and uses thereof

RIGEL PHARMACEUTICALS INC3 citations73
US9845307B2Dec 19, 2017

Nrf2 activating compounds and uses thereof

RIGEL PHARMACEUTICALS INC2 citations73
US9801866B2Oct 31, 2017

Fumarate analogs and uses thereof

RIGEL PHARMACEUTICALS INC3 citations73
US9732070B2Aug 15, 2017

Protein kinase C inhibitors and uses thereof

RIGEL PHARMACEUTICALS INC4 citations73
US9701647B2Jul 11, 2017

Tetrazolones as a carboxylic acid bioisosteres

RIGEL PHARMACEUTICALS INC2 citations73
US9682976B2Jun 20, 2017

Protein kinase C inhibitors and uses thereof

RIGEL PHARMACEUTICALS INC3 citations73
US9181222B2Nov 10, 2015

Protein kinase C inhibitors and uses thereof

RIGEL PHARMACEUTICALS INC4 citations73
US9169249B2Oct 27, 2015

Protein kinase C inhibitors and uses thereof

RIGEL PHARMACEUTICALS INC4 citations73
US8754251B2Jun 17, 2014

Cyclopropyl PIDA boronate

RIGEL PHARMACEUTICALS INC4 citations73
US9149475B2Oct 6, 2015

Protein kinase C inhibitors and uses thereof

RIGEL PHARMACEUTICALS INC5 citations71
US11279686B2Mar 22, 2022

Nrf2 activating compounds and uses thereof

RIGEL PHARMACEUTICALS INC0 citations63
US9845311B2Dec 19, 2017

Nrf2 activating compounds and uses thereof

RIGEL PHARMACEUTICALS INC1 citations63
US9439888B2Sep 13, 2016

Tetrazolones as a carboxylic acid bioisosteres

RIGEL PHARMACEUTICALS INC2 citations63
US11129819B2Sep 28, 2021

Fumarate analogs and uses thereof

RIGEL PHARMACEUTICALS INC0 citations62
US10844040B2Nov 24, 2020

Nrf2 activating compounds and uses thereof

RIGEL PHARMACEUTICALS INC0 citations52
US10792282B2Oct 6, 2020

Protein kinase C inhibitors and uses thereof

RIGEL PHARMACEUTICALS INC0 citations52
US10647697B2May 12, 2020

Nrf2 activating compounds and uses thereof

RIGEL PHARMACEUTICALS INC0 citations52
US10556881B2Feb 11, 2020

Nrf2 activating compounds and uses thereof

RIGEL PHARMACEUTICALS INC0 citations52
US10493066B2Dec 3, 2019

Fumarate analogs and uses thereof

RIGEL PHARMACEUTICALS INC0 citations52
US10450280B2Oct 22, 2019

Tetrazolones as a carboxylic acid bioisosteres

RIGEL PHARMACEUTICALS INC0 citations52
US10005777B2Jun 26, 2018

Protein kinase C inhibitors and uses thereof

RIGEL PHARMACEUTICALS INC0 citations52
US9108990B2Aug 18, 2015

Cyclopropyl MIDA boronate

RIGEL PHARMACEUTICALS INC0 citations52
US9062068B2Jun 23, 2015

Protein kinase C inhibitors and uses thereof

RIGEL PHARMACEUTICALS INC0 citations52
US11174246B2Nov 16, 2021

Direct AMPK activators

RIGEL PHARMACEUTICALS INC0 citations49

NFLECTION THERAPEUTICS INC

8 patents

TERRAN BIOSCIENCES INC

4 patents

RENOVIS INC

2 patents

DUNCTON MATTHEW

2 patents

HOLLAND SACHA

1 patent

DECIDUOUS THERAPEUTICS INC

1 patent

WEI ZHI-LIANG

1 patent